Anti-STAMBPL1 monoclonal antibody

Pre-made anti-STAMBPL1 monoclonal antibody(mab)-benchmark antibody for ELISA, affinity binding assay, drug discovery and mechanism of action (MOA) research

Target products collectionGo to STAMBPL1/STAMBPL1 products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)


Product information

Catalog No.Product NameSpecies Reactivity
GM-Tg-hg-IP2756-Ab-1/ GM-Tg-hg-IP2756-Ab-2Anti-Human STAMBPL1 monoclonal antibodyHuman
GM-Tg-rg-IP2756-Ab-1/ GM-Tg-rg-IP2756-Ab-2Anti-Rat STAMBPL1 monoclonal antibodyRat
GM-Tg-mg-IP2756-Ab-1/ GM-Tg-mg-IP2756-Ab-2Anti-Mouse STAMBPL1 monoclonal antibodyMouse
GM-Tg-cynog-IP2756-Ab-1/ GM-Tg-cynog-IP2756-Ab-2Anti-Cynomolgus/ Rhesus macaque STAMBPL1 monoclonal antibodyCynomolgus/ Rhesus macaque
GM-Tg-felg-IP2756-Ab-1/ GM-Tg-felg-IP2756-Ab-2Anti-Feline STAMBPL1 monoclonal antibodyFeline
GM-Tg-cang-IP2756-Ab-1/ GM-Tg-cang-IP2756-Ab-2Anti-Canine STAMBPL1 monoclonal antibodyCanine
GM-Tg-bovg-IP2756-Ab-1/ GM-Tg-bovg-IP2756-Ab-2Anti-Bovine STAMBPL1 monoclonal antibodyBovine
GM-Tg-equg-IP2756-Ab-1/ GM-Tg-equg-IP2756-Ab-2Anti-Equine STAMBPL1 monoclonal antibodyEquine

Size: 1mg | 10mg | 100mg



Product Description

Catalog No.GM-Tg-hg-IP2756-Ab-1/ GM-Tg-hg-IP2756-Ab-2; GM-Tg-rg-IP2756-Ab-1/ GM-Tg-rg-IP2756-Ab-2;
GM-Tg-mg-IP2756-Ab-1/ GM-Tg-mg-IP2756-Ab-2; GM-Tg-cynog-IP2756-Ab-1/ GM-Tg-cynog-IP2756-Ab-2;
GM-Tg-felg-IP2756-Ab-1/ GM-Tg-felg-IP2756-Ab-2; GM-Tg-cang-IP2756-Ab-1/ GM-Tg-cang-IP2756-Ab-2;
GM-Tg-bovg-IP2756-Ab-1/ GM-Tg-bovg-IP2756-Ab-2; GM-Tg-equg-IP2756-Ab-1/ GM-Tg-equg-IP2756-Ab-2
Products NameAnti-STAMBPL1 monoclonal antibody
Formatmab
Target NameSTAMBPL1
Protein Sub-locationIntrocelluar Protein
Category of antibody
Derivation (species)Mouse
CH1+2+3 Isotype
(Receptor identification)
IgG
Type of Light Chain (VD-LC)N/A
Expression platformMammalian Expression
Bioactivity validationBinding affinity is validated by ELISA with recombinant soluble protein antigen. The potency in neutralizing, inhibiting or blocking of the target protein is not detected.
TagFc
Products descriptionPre-made anti-STAMBPL1 monoclonal antibody(mab) is expressed by mammalian cell line as a benchmark antibody for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic)
Purity Purity: ≥95% (SDS-PAGE)
Application Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation & Reconstitution Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4);
For PSB2, reconstituted with 0.9% sodium chloride;
For PBS, reconstituted with ddH2O.
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference




    Data / case study


    Click to get more Data / Case study about the product.



    Associated products


    CategoryCat No.Products Name
    Target AntigenGM-Tg-g-IP2756-Ag-1Recombinant multi-species STALP/ STAMBPL1/ ALMalpha protein


    Target information

    Target IDGM-IP2756
    Target NameSTAMBPL1
    Gene ID57559,76630,687696,694629,477586,101093298,538785,100062209
    Gene Symbol and Synonyms1700095N21Rik,8230401J17Rik,ALMalpha,AMSH-FP,AMSH-LP,bA399O19.2,STAMBPL1
    Uniprot AccessionQ96FJ0
    Uniprot Entry NameSTALP_HUMAN
    Protein Sub-locationIntrocelluar Protein
    Category
    DiseaseN/A
    Gene EnsemblENSG00000138134
    Target ClassificationN/A

    The target: STAMBPL1, gene name: STAMBPL1, also named as ALMalpha, AMSH-FP, AMSH-LP, bA399O19.2. Predicted to enable Lys63-specific deubiquitinase activity and thiol-dependent deubiquitinase. Predicted to be involved in protein K63-linked deubiquitination. Located in membrane. [provided by Alliance of Genome Resources, Apr 2022].



    About Gmab

    GDU
    GDU



    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.

    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.